1887

Journal of Medical Microbiology logo

Volume 72, Issue 6

Insights into the challenging multi-country outbreak of Mpox: a comprehensive review No Access

Abstract

Human monkeypox virus (hMpoxV) is of zoonotic origin and is closely related to the once-dreaded smallpox virus. It is largely endemic to the African continent but has moved out of the endemic regions as sporadic clusters in the past 20 years, raising concerns worldwide. Human Mpox is characterized by a mild to severe, self-limiting infection, with mortality ranging from less than 1% to up to 10% during different outbreaks caused by different clades of MpoxV. Bushmeat hunting is one of the primary reasons for its transmission from animals to humans. Various international and national health regulatory bodies are closely monitoring the disease and have laid down guidelines to manage and prevent hMpox cases. Emergency Use Status has been granted to Tecovirimat and Brincidofovir to treat severe cases and vaccination with the smallpox vaccine is recommended for high-risk group individuals. Strategies to repurpose and discover novel therapeutics and vaccines to control the outbreak are being researched. The current Mpox outbreak that has mainly affected men as approximately 96% of all cases are reported in men, is probably the result of a complex intersection of various factors. This necessitates a strong One Health response coordination involving human, animal and environmental health institutions. This review is an attempt to provide an all-inclusive overview of the biology, history, epidemiology, pathophysiology, diagnosis and management of hMpox in context to the recent 2022–2023 multi-country outbreak which is termed by WHO a ‘Public Health Emergency of International Concern (PHEIC)’.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): case management , clades , diagnosis , epidemiology , interventions , Monkeypox , Mpox , One Health approach , pathophysiology , Public Health Emergency of International Concern (PHEIC) and social stigma regarding Mpox
© 2023 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001725
2023-06-28
2024-05-02
Loading full text...

Full text loading...

References

  1. De Baetselier I, Van Dijck C, Kenyon C, Coppens J, Michiels J et al. Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium. Nat Med 2022; 28:2288–2292 [View Article]
     [Google Scholar]
  2. Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs 2022; 82:957–963 [View Article] [PubMed]
     [Google Scholar]
  3. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLOS Negl Trop Dis 2022; 16:e0010141 [View Article] [PubMed]
     [Google Scholar]
  4. Guarner J, Del Rio C, Malani PN. Monkeypox in 2022-What clinicians need to know. JAMA 2022; 328:139–140 [View Article] [PubMed]
     [Google Scholar]
  5. Vivancos R, Anderson C, Blomquist P, Balasegaram S, Bell A et al. Community transmission of monkeypox in the United Kingdom, April to May 2022. Euro Surveill 2022; 27:2200422 [View Article] [PubMed]
     [Google Scholar]
  6. Moore MJ, Rathish B, Monkeypox F. Monkeypox. In StatPearls Treasure Island (FL): StatPearls Publishing; 2022 [PubMed]
     [Google Scholar]
  7. Adler H, Gould S, Hine P, Snell LB, Wong W et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 2022; 22:1153–1162 [View Article] [PubMed]
     [Google Scholar]
  8. Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA et al. Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health 2023; 16:531–541 [View Article] [PubMed]
     [Google Scholar]
  9. Kmiec D, Kirchhoff F. Monkeypox: a new threat?. IJMS 2022; 23:7866 [View Article]
     [Google Scholar]
  10. McFadden G. Poxvirus tropism. Nat Rev Microbiol 2005; 3:201–213 [View Article] [PubMed]
     [Google Scholar]
  11. Erez N, Achdout H, Milrot E, Schwartz Y, Wiener-Well Y et al. Diagnosis of imported monkeypox, Israel, 2018. Emerg Infect Dis 2019; 25:980–983 [View Article] [PubMed]
     [Google Scholar]
  12. Shchelkunov SN, Totmenin AV, Safronov PF, Mikheev MV, Gutorov VV et al. Analysis of the Monkeypox Virus Genome. Virology 2002; 297:172–194 [View Article]
     [Google Scholar]
  13. Isidro J, Borges V, Pinto M, Sobral D, Santos JD et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med 2022; 28:2220–2221 [View Article] [PubMed]
     [Google Scholar]
  14. Gigante CM, Korber B, Seabolt MH, Wilkins K, Davidson W et al. Multiple lineages of monkeypox virus detected in the United States, 2021–2022. Science 2022; 378:560–565 [View Article]
     [Google Scholar]
  15. Wang L, Shang J, Weng S, Aliyari SR, Ji C et al. Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022. J Med Virol 2023; 95:e28036 [View Article] [PubMed]
     [Google Scholar]
  16. Scarpa F, Sanna D, Azzena I, Cossu P, Locci C et al. Genetic Variability of the Monkeypox Virus Clade IIb B.1. J Clin Med 2022; 11:6388 [View Article] [PubMed]
     [Google Scholar]
  17. Yang Q, Xia D, Shah Syed AA, Wang Z, Shi Y. Highly accurate protein structure prediction and drug screen of monkeypox virus proteome - PMC; 2022 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367171/ [PubMed]
  18. Zheng L, Meng J, Lin M, Lv R, Cheng H et al. Structure prediction of the entire proteome of monkeypox variants. Acta Materia Medica 2022; 1: [View Article]
     [Google Scholar]
  19. Keasey S, Pugh C, Tikhonov A, Chen G, Schweitzer B et al. Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. PLoS One 2010; 5:e15547 [View Article]
     [Google Scholar]
  20. World Health Organisation Monkeypox; 2022 https://www.who.int/news-room/fact-sheets/detail/monkeypox accessed 14 August 2022
  21. World Health Organization Multi-country Outbreak of Mpox. External Situation Report 13, (05 Jan 2023); 2023 https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report--13---5-january-2023
  22. World Health Organization Multi-country Outbreak of Mpox. External Situation Report 22, (11May 2023); 2023 https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report--22---11-may-2023
  23. Rao AK, Schulte J, Chen T-H, Hughes CM, Davidson W et al. Monkeypox in a traveler returning from Nigeria - Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep 2022; 71:509–516 [View Article] [PubMed]
     [Google Scholar]
  24. Parker S, Buller RM. A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. Future Virol 2013; 8:129–157 [View Article] [PubMed]
     [Google Scholar]
  25. Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am 2019; 33:1027–1043 [View Article] [PubMed]
     [Google Scholar]
  26. Oladimeji O. The paradigm shift in Monkeypox epidemiology. Nature 2022 [View Article]
     [Google Scholar]
  27. Huang Y, Mu L, Wang W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduct Target Ther 2022; 7:373 [View Article] [PubMed]
     [Google Scholar]
  28. Mpox (monkeypox) and animals - Canada.ca Mpox (Monkeypox) and Animals - Canada.ca; 2023 https://www.canada.ca/en/public-health/services/diseases/mpox/risks/animals.html accessed 23 April 2023
  29. Center for Food Security and Public Health factsheet on Monkeypox; 2022 www.cfsph.iastate.edu/Factsheets
  30. Li K, Yuan Y, Jiang L, Liu Y, Liu Y et al. Animal host range of mpox virus. J Med Virol 2023; 95:e28513 [View Article] [PubMed]
     [Google Scholar]
  31. Tesh RB, Watts DM, Sbrana E, Siirin M, Popov VL et al. Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox Virus. Emerg Infect Dis 2004; 10:1563–1567 [View Article]
     [Google Scholar]
  32. Adalja A, Inglesby T. A novel International Monkeypox outbreak. Ann Intern Med 2022; 175:1175–1176 [View Article] [PubMed]
     [Google Scholar]
  33. World Health Organisation Monkeypox: experts give virus variants new names (2022, August12). WHO; 2022 https://www.who.int/news/item/12-08-2022-monkeypox--experts-give-virus-variants-new-names accessed 21 August 2022
  34. World Health Organisation WHO recommends new name for monkeypox disease (2022,November 28). WHO Recommends New Name for Monkeypox Disease; 2022 https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease accessed 11 December 2022
  35. Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull 1998; 54:693–702 [View Article] [PubMed]
     [Google Scholar]
  36. Hoff NA, Doshi RH, Colwell B, Kebela-Illunga B, Mukadi P et al. Evolution of a disease surveillance system: an increase in reporting of human monkeypox disease in the democratic republic of the Congo, 2001-2013. Int J Trop Dis Health 2017; 25:IJTDH.35885 [View Article] [PubMed]
     [Google Scholar]
  37. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLOS Negl Trop Dis 2019; 13:e0007791 [View Article] [PubMed]
     [Google Scholar]
  38. Centers for Disease Control and Prevention History of Smallpox | Smallpox | CDC; 2021 https://www.cdc.gov/smallpox/history/history.html accessed 29 August 2022
  39. Gould SA, Oniana B, Spencer A O, Furneaux J, Grieves J et al. Air and surface sampling of Monkeypox virus in a UK hospital. Lancet Microb 20221–8 [View Article]
     [Google Scholar]
  40. Centers for Disease Control and Prevention Signs and Symptoms | Mpox | CDC (October 18,2022); 2022 https://www.cdc.gov/poxvirus/monkeypox/symptoms/index.html accessed 29 August 2022
  41. Mauldin MR, McCollum AM, Nakazawa YJ, Mandra A, Whitehouse ER et al. Exportation of Monkeypox Virus From the African Continent | The Journal of Infectious Diseases | Oxford Academic. OUP Academic; 2022 https://academic.oup.com/jid/article/225/8/1367/5901023#350069114 accessed 9 October 2022
  42. World Health Organization Multi-country Outbreak of Mpox. External Situation Report 12, (14Dec 2022); 2022 https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-12--14-december-2022
  43. Times TS. Fear of social stigma preventing Asians from monkeypox testing; 2022 https://theshillongtimes.com/2022/08/13/fear-of-social-stigma-preventing-asians-from- monkeypox-testing/
  44. UNAIDS UNAIDS warns that stigmatizing language on Monkeypox jeopardises public health.UNAIDS Warns That Stigmatizing Language on Monkeypox Jeopardises Public Health | UNAIDS; 2022 www.unaids.org. https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2022/may/20220522_PR_Monkeypox
  45. World Health Organization Perceptions of monkeypox from those most at risk: men who have sex with men having multiple sexual partners; 2022 https://www.who.int/europe/news/item/26-08-2022-perceptions-of-monkeypox-from-those-most-at-risk--men-who-have-sex-with-men-having-multiple-sexual-partners accessed 15 September 2022
  46. Kim J. Monkeypox messaging matters to reduce stigma: NPR. NPR.Org; 2022 www.npr.org. https://www.npr.org/2022/07/31/1114670483/monkeypox-messaging-stigma
  47. Chavda VP, Vora LK, Apostolopoulos V. Monkeypox: a new face of outbreak. Expert Rev Vaccines 2022; 21:1537–1540 [View Article] [PubMed]
     [Google Scholar]
  48. Ward T, Christie R, Paton RS, Cumming F, Overton CE. Transmission dynamics of monkeypox in the United Kingdom: contact tracing study. BMJ 2022e073153 [View Article]
     [Google Scholar]
  49. Fowotade A, Fasuyi TO, Bakare RA. Re-emergence of monkeypox in Nigeria: a cause for concern and public enlightenment. Af J Clin Exp Micro 2018; 19:307 [View Article]
     [Google Scholar]
  50. Yong SEF, Ng OT, Ho ZJM, Mak TM, Marimuthu K et al. Imported Monkeypox, Singapore. Emerg Infect Dis 2020; 26:1826–1830 [View Article] [PubMed]
     [Google Scholar]
  51. Delaney KP, Sanchez T, Hannah M, Edwards OW, Carpino T et al. Strategies adopted by gay, bisexual, and other men who have sex with men to prevent monkeypox virus transmission - United States, August 2022. MMWR Morb Mortal Wkly Rep 2022; 71:1126–1130 [View Article] [PubMed]
     [Google Scholar]
  52. Almehmadi M, Allahyani M, Alsaiari AA, Alshammari MK, Alharbi AS et al. A glance at the development and patent literature of tecovirimat: the first-in-class therapy for emerging monkeypox outbreak. Viruses 2022; 14:1870 [View Article] [PubMed]
     [Google Scholar]
  53. Minhaj FS, Ogale YP, Whitehill F, Schultz J, Foote M et al. Monkeypox outbreak—Nine states, May 2022. Am J Transplant 2022; 22:2104–2110 [View Article]
     [Google Scholar]
  54. GOI, Ministry of Health and Family Welfare Guidelines for Management of Monkeypox Disease (2022, May 31); 2022 https://main.mohfw.gov.in/diseasealerts-0 accessed 12 December 2022
  55. Centers for Disease Control and Prevention Monkeypox in the U.S (2022, October 31); 2022 https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html accessed 11 December 2022
  56. Chan-Tack KM, Harrington PR, Choi S-Y, Myers L, O’Rear J et al. Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox. Lancet Infect Dis 2019; 19:e221–e224 [View Article] [PubMed]
     [Google Scholar]
  57. U.S. Food and Drug Administration (FDA) FDA approves the first drug with an indication fortreatment of smallpox. (2018, July 13; 2018 https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-indication-treatment-smallpox accessed 11 December 2022
  58. Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med 2018; 379:44–53 [View Article] [PubMed]
     [Google Scholar]
  59. Russo AT, Grosenbach DW, Chinsangaram J, Honeychurch KM, Long PG et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther 2021; 19:331–344 [View Article] [PubMed]
     [Google Scholar]
  60. Sherwat A, Brooks JT, Birnkrant D, Kim P. Tecovirimat and the treatment of monkeypox - past, present, and future considerations. N Engl J Med 2022; 387:579–581 [View Article] [PubMed]
     [Google Scholar]
  61. Frenois-Veyrat G, Gallardo F, Gorgé O, Marcheteau E, Ferraris O et al. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations. Nat Microbiol 2022; 7:1951–1955 [View Article] [PubMed]
     [Google Scholar]
  62. European Medicines Agency (EMA) Tecovirimat SIGA; 2021 https://www.ema.europa.eu/en/medicines/human/ EPAR/tecovirimat-siga accessed 2 November 2022
  63. Tippin TK, Morrison ME, Brundage TM, Momméja-Marin H. Brincidofovir is not a substrate for the human organic anion transporter 1: a mechanistic explanation for the lack of nephrotoxicity observed in clinical studies. Ther Drug Monit 2016; 38:777–786 [View Article] [PubMed]
     [Google Scholar]
  64. Grossi IM, Foster SA, Gainey MR, Krile RT, Dunn JA et al. Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits. Antiviral Res 2017; 143:278–286 [View Article] [PubMed]
     [Google Scholar]
  65. Hutson CL, Kondas AV, Mauldin MR, Doty JB, Grossi IM et al. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. mSphere 2021; 6:e00927–20 [View Article] [PubMed]
     [Google Scholar]
  66. Trost LC, Rose ML, Khouri J, Keilholz L, Long J et al. The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease. Antiviral Res 2015; 117:115–121 [View Article] [PubMed]
     [Google Scholar]
  67. Chan-Tack K, Harrington P, Bensman T, Choi SY, Donaldson E et al. Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration’S Evaluation. Antiviral Res 2021; 195:105182 [View Article] [PubMed]
     [Google Scholar]
  68. U.S. Food and Drug Administration (FDA) FDA approves drug to treat smallpox. (2021, June 4); 2021 https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-smallpox accessed 30 October 2022
  69. Lederman ER, Davidson W, Groff HL, Smith SK, Warkentien T et al. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. J Infect Dis 2012; 206:1372–1385 [View Article] [PubMed]
     [Google Scholar]
  70. Vora S, Damon I, Fulginiti V, Weber SG, Kahana M et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis 2008; 46:1555–1561 [View Article] [PubMed]
     [Google Scholar]
  71. Quenelle DC, Prichard MN, Keith KA, Hruby DE, Jordan R et al. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses. Antimicrob Agents Chemother 2007; 51:4118–4124 [View Article] [PubMed]
     [Google Scholar]
  72. Wittek R. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. Int J Infect Dis 2006; 10:193–201 [View Article] [PubMed]
     [Google Scholar]
  73. Poland GA, Kennedy RB, Tosh PK. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect Dis 2022; 22:e349–e358 [View Article] [PubMed]
     [Google Scholar]
  74. Centers for Disease Control and Prevention Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022 U.S Monkeypox Outbreak (2022, October 19); 2022 https://www.cdc.gov/poxvirus/monkeypox/clinicians/smallpox-vaccine.html accessed 11 December 2022
  75. Harris E. What to know about monkeypox. JAMA 2022; 327:2278–2279 [View Article] [PubMed]
     [Google Scholar]
  76. Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun 2022; 131:102855 [View Article] [PubMed]
     [Google Scholar]
  77. Center for Disease Control and Prevention Vaccines | Smallpox | CDC. (2022, August 8).Vaccines | Smallpox | CDC; 2022 https://www.cdc.gov/smallpox/clinicians/vaccines.html accessed 11 December 2022
  78. Eteng WE. Notes from the field: responding to an outbreak of monkeypox. Centers for Disease Control and Prevention; 2018 https://www.cdc.gov/mmwr/volumes/67/wr/mm6737a5.html accessed 11 December 2022
  79. Sharma S. How WHOâs âOne Healthâ Program Can Help India Tackle Monkeypox-; 2022 https://carnegieindia.org/2022/08/08/how-who-s-one-health-program-can-help-india accessed 13 August 2022
  80. Shah R, Mohanty A, Siddiq A, Singh P, Abdelaal A et al. Monkeypox reported in India - South East Asia Region: health and economic challenges. Lancet Reg Health Southeast Asia 2022; 4:100063 [View Article] [PubMed]
     [Google Scholar]
  81. Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Cureus | Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation. Monkeypox: AComprehensive Review of Transmission, Pathogenesis, and Manifestation; 2022 https://www.cureus.com/articles/100707 accessed 30 October 2022
  82. Perez Duque M, Ribeiro S, Martins JV, Casaca P, Leite PP et al. Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022. Euro Surveill 2022; 27:2200424 [View Article] [PubMed]
     [Google Scholar]
  83. Gennaro FD, Veronese N, Marotta C, Shin JI, Koyanagi A et al. Human monkeypox: a comprehensive narrative review and analysis of the Public Health implications. Microorganisms 2022; 10:1633 [View Article] [PubMed]
     [Google Scholar]
  84. Noe S, Zange S, Seilmaier M, Antwerpen MH, Fenzl T et al. Clinical and virological features of first human monkeypox cases in Germany. Infection 2022; 51:265–270 [View Article] [PubMed]
     [Google Scholar]
  85. Saijo M, Ami Y, Suzaki Y, Nagata N, Iwata N et al. Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: differentiation of Congo Basin and West African MPXV strains. Jpn J Infect Dis 2008; 61:140–142 [View Article] [PubMed]
     [Google Scholar]
  86. Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci 2010; 107:16262–16267 [View Article] [PubMed]
     [Google Scholar]
  87. Yadav PD, Reghukumar A, Sahay RR, K S, Shete AM et al. First two cases of monkeypox virus infection in travellers returned from UAE to India, July 2022. J Infect 2022; 85:e145–e148 [View Article] [PubMed]
     [Google Scholar]
  88. Costello V, Sowash M, Gaur A, Cardis M, Pasieka H et al. Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerg Infect Dis 2022; 28:1002–1005 [View Article] [PubMed]
     [Google Scholar]
  89. Girometti RB, Bracchi M, Heskin J, McOwan A, Tittle V et al. Reaching the vulnerable without stigma. Reaching the Vulnerable Without Stigma - ScienceDirect; 2022 https://www.sciencedirect.com/science/article/pii/S147330992200456X accessed 11 December 2022
  90. Wallace LL. There’s Lots of Confusion and Stigma Around Monkeypox—Let’s Clear It Up SELF; 2022 https://www.self.com/story/monkeypox-stigma
  91. Sklenovská N, Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health 2018; 6: [View Article]
     [Google Scholar]
  92. Yoshida F. SymBio announces exclusive global license agreement with chimerix for antiviral drug, brincidofovir. SymBio Pharmaceuticals Limited; 2019 https://www.symbiopharma.com/news_e/20191001e.pdf accessed 26 August 2022
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001725
Loading
Insights into the challenging multi-country outbreak of Mpox: a comprehensive review
J. Med. Microbiol. 72, 001725 (2023); https://doi.org/10.1099/jmm.0.001725
/content/journal/jmm/10.1099/jmm.0.001725
/content/journal/jmm/10.1099/jmm.0.001725
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error